In Humira kickbacks case, disgruntled AbbVie investors score class-action status
In Humira kickbacks case, disgruntled AbbVie investors score class-action status [...]
Kyowa Kirin’s awareness message for physicians goes beyond skin-deep for Poteligeo rare cancer drug
Kyowa Kirin’s awareness message for physicians goes beyond skin-deep for [...]
Hikma bolsters injectables franchise with $425M deal for Custopharm, but FTC review looms
Hikma bolsters injectables franchise with $425M deal for Custopharm, but [...]
Facing class action lawsuit over insulin pricing, Novo Nordisk inks $100M settlement with disgruntled investors
Facing class action lawsuit over insulin pricing, Novo Nordisk inks [...]
Gilead, Merck and others slapped with ‘pay-for-delay’ lawsuits over lucrative HIV and cholesterol meds
Gilead, Merck and others slapped with ‘pay-for-delay’ lawsuits over lucrative [...]
FDA’s ongoing review of accelerated cancer approvals targets 2 drugs from Secura and Aurobindo
FDA’s ongoing review of accelerated cancer approvals targets 2 drugs [...]
Responding to global vaccine demand, Cytiva pledges $52.5M to build South Korean factory
Responding to global vaccine demand, Cytiva pledges $52.5M to build [...]
Regeneron and Roche’s COVID drug wins WHO backing, but agency calls for lower prices and better access
Regeneron and Roche’s COVID drug wins WHO backing, but agency [...]
Merck will pay royalties on next-gen pneumococcal shot to settle Pfizer patent fight
Merck will pay royalties on next-gen pneumococcal shot to settle [...]
AstraZeneca, Merck target broad use of Lynparza in prostate cancer as PARP rivals Pfizer, J&J, Clovis loom
AstraZeneca, Merck target broad use of Lynparza in prostate cancer [...]